Rauch, T. (2010). Efficacy and safety of linagliptin (BI 1356), a novel inhibitor of dipeptidyl-peptidase 4 (DPP-4), in animal models and clinical studies in healthy volunteers and patients with type 2 diabetes mellitus.
Chicago Style (17th ed.) CitationRauch, Thomas. Efficacy and Safety of Linagliptin (BI 1356), a Novel Inhibitor of Dipeptidyl-peptidase 4 (DPP-4), in Animal Models and Clinical Studies in Healthy Volunteers and Patients with Type 2 Diabetes Mellitus. 2010.
MLA (9th ed.) CitationRauch, Thomas. Efficacy and Safety of Linagliptin (BI 1356), a Novel Inhibitor of Dipeptidyl-peptidase 4 (DPP-4), in Animal Models and Clinical Studies in Healthy Volunteers and Patients with Type 2 Diabetes Mellitus. 2010.
Warning: These citations may not always be 100% accurate.